跳到正文
openFDA 已分级药品召回执法报告·· 12 天前精选AI 评分72

FDA 执法报告 D-0169-2027 将 Fresenius DELFLEX 腹膜透析液召回列为 Class II

FDA drug enforcement D-0169-2027: Fresenius Medical Care Renal Therapies Group, LLC — Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.

AI 导读

FDA 执法报告 D-0169-2027 将 Fresenius Medical Care 肾治疗集团 DELFLEX 腹膜透析液召回列为 Class II,原因为无菌保证不足。

推荐理由

记录给出两条受影响批号、Class II 分类与无菌保证不足的原因描述,可用于核对召回范围与投诉内容。

正文 · 原文

FDA drug recall enforcement report — D-0169-2027

Report issued: 2026-11-11. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "350 Merrimack St",

"address_2": "",

"center_classification_date": "20261103",

"city": "Lawrence",

"classification": "Class II",

"code_info": "Lot#: 25HGPD037, Exp 12/31/2026; 26CGPD074, Exp 9/30/2027.",

"country": "United States",

"distribution_pattern": "Nationwide in the USA.",

"event_id": "100130",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {

"application_number": [

"NDA020171"

],

"brand_name": [

"DELFLEX"

],

"generic_name": [

"DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"

],

"is_original_packager": [

true

],

"manufacturer_name": [

"Fresenius Medical Care de Mexico, S.A. de C.V."

],

"package_ndc": [

"46163-209-92",

"46163-209-94",

"46163-209-95",

"46163-212-95",

"46163-212-92",

"46163-212-94",

"46163-206-92",

"46163-206-94",

"46163-206-95"

],

"product_ndc": [

"46163-206",

"46163-209",

"46163-212"

],

"product_type": [

"HUMAN PRESCRIPTION DRUG"

],

"route": [

"INTRAPERITONEAL"

],

"spl_id": [

"5f14959c-adcd-923c-e063-6294a90ab6de"

],

"spl_set_id": [

"a98facd6-9daa-4d37-8209-63a0599dbfaa"

],

"substance_name": [

"DEXTROSE MONOHYDRATE",

"SODIUM CHLORIDE",

"SODIUM LACTATE",

"CALCIUM CHLORIDE",

"MAGNESIUM CHLORIDE"

],

"unii": [

"TU7HW0W0QT",

"LX22YL083G",

"02F3473H9O",

"451W47IQ8X",

"M4I0D6VV5M"

]

},

"postal_code": "01843-1748",

"product_description": "DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,500 mL Single dose bag, Sterile and Non-Pyrogenic, Rx only, CAT. NO. 054-25321. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-206-94",

"product_quantity": "1,065 cases (5 bags per case)",

"product_type": "Drugs",

"reason_for_recall": "Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.",

"recall_initiation_date": "20261014",

"recall_number": "D-0169-2027",

"recalling_firm": "Fresenius Medical Care Renal Therapies Group, LLC",

"report_date": "20261111",

"state": "MA",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov